ATE15604T1 - Biostimulierendes mittel. - Google Patents

Biostimulierendes mittel.

Info

Publication number
ATE15604T1
ATE15604T1 AT83105674T AT83105674T ATE15604T1 AT E15604 T1 ATE15604 T1 AT E15604T1 AT 83105674 T AT83105674 T AT 83105674T AT 83105674 T AT83105674 T AT 83105674T AT E15604 T1 ATE15604 T1 AT E15604T1
Authority
AT
Austria
Prior art keywords
hydrolyzate
weight
inositephosphoric
biostimulant
lyophylized
Prior art date
Application number
AT83105674T
Other languages
German (de)
English (en)
Inventor
Michail Stefanov Dr Med Kirov
Pentscho Varbanov Dipl-I Burov
Ivan Christov Dipl- Kovatschev
Ivan Christov Dipl- Radoslavov
Original Assignee
Dso Pharmachim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dso Pharmachim filed Critical Dso Pharmachim
Application granted granted Critical
Publication of ATE15604T1 publication Critical patent/ATE15604T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT83105674T 1982-06-09 1983-06-09 Biostimulierendes mittel. ATE15604T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823221827 DE3221827A1 (de) 1982-06-09 1982-06-09 Biostimulierendes mittel
EP83105674A EP0098975B1 (de) 1982-06-09 1983-06-09 Biostimulierendes Mittel

Publications (1)

Publication Number Publication Date
ATE15604T1 true ATE15604T1 (de) 1985-10-15

Family

ID=6165747

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83105674T ATE15604T1 (de) 1982-06-09 1983-06-09 Biostimulierendes mittel.

Country Status (7)

Country Link
EP (1) EP0098975B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5962528A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE15604T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU562517B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3221827A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR77543B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO832057L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ242744A (en) * 1991-05-14 1997-02-24 Ernir Snorrason Use of a cholinesterase inhibitor (eg a galanthamine derivative) for treating fatigue
RU2124360C1 (ru) * 1992-11-06 1999-01-10 Борис Геннадиевич Хорхорин Способ повышения иммунитета
CH688760A5 (de) * 1995-04-28 1998-03-13 Synergen Ag Topisches Praeparat zur Foerderung des Muskelaufbaus.
DE19537494C2 (de) * 1995-09-25 1997-10-02 Desitin Arzneimittel Gmbh Kreatin zum Schutz von neuralem Gewebe
WO1998000148A1 (de) * 1996-06-28 1998-01-08 Ipr-Institute For Pharmaceutical Research Ag Arzneimittelzubereitungen, enthaltend kreatin mit mindestens einem salz von calcium, magnesium, mangan oder zink
EP1150695B1 (en) * 1999-01-11 2007-02-28 Atanas Russinov Djananov Herbal supplement for increased muscle strength and endurance for athletes
US8603546B2 (en) 1999-01-11 2013-12-10 Herbaceuticals Inc. Herbal supplement for increased muscle strength and endurance for athletes
NZ522317A (en) * 2000-04-19 2004-05-28 Humanetics Corp A combination of pinitol and creatine to enhance uptake and retention of creatine in muscle tissue

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2254777A (en) * 1936-08-26 1941-09-02 Walther H Duisberg Process of producing artificial staple fibers resembling wool
GB1012121A (en) * 1961-03-13 1965-12-08 Yamanouchi Pharma Co Ltd A method of preparing a pharmacologically active protein material from royal bee jelly
FR1326611A (fr) * 1962-04-05 1963-05-10 Procédé d'activation de la gelée royale d'abeilles, produits pour la réalisationdu procédé et produits conformes à ceux obtenus par le présent procédé ou procédé similaire

Also Published As

Publication number Publication date
GR77543B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-24
EP0098975B1 (de) 1985-09-18
JPS5962528A (ja) 1984-04-10
DE3221827A1 (de) 1983-12-15
EP0098975A1 (de) 1984-01-25
AU1543283A (en) 1983-12-15
NO832057L (no) 1983-12-12
AU562517B2 (en) 1987-06-11

Similar Documents

Publication Publication Date Title
ATE110531T1 (de) Hochsaures system enthaltende nahrungsformulierungen.
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
DE3751666D1 (de) Flüssige konzentrierte Zusammensetzung zur Herstellung von Phosphatierlösungen die Mangan enthalten
IL66256A (en) Water containing compositions comprising alkali metal salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants
GB2187955B (en) Improvements in or relating to the treatment of sickle cell disease
DK0631772T3 (da) Retinoidholdig sammensætning
DE58900685D1 (de) Kosmetisches praeparat auf basis von retinolpalmitat.
ATE15604T1 (de) Biostimulierendes mittel.
DE3269331D1 (en) Arene-carboxylic acid derivatives used as agents having an anti-seborrhea effect contained in cosmetic compositions
DE3673786D1 (de) Herstellung von indol-alpha-ketosaeure aus alpha-aminosaeure, insbesondere indolpyruvicsaeure.
ATE11627T1 (de) Verwendung von waessrigen natrium- oder kaliummethioninat-loesungen zur supplementierung von mischfuttern mit methionin.
OA07904A (fr) Composition nutritive de l'acide alpha-cétois un de ses sels.
JPS57171908A (en) Agent for preventing falling-out of hair, promoting growth and occurrence of hair
ES8501380A1 (es) Un procedimiento para preparar l-tiazolidin-4-carboxilato de zinc
ATE6057T1 (de) Das pflanzenwachstum regulierende zusammensetzungen, die als aktive substanz derivate von 2-methylen-succinamidsaeure enthalten, und derivate dieser saeure, die in diesen zusammensetzungen verwendbar sind.
ATE56867T1 (de) Etofenamat-zubereitung.
EP0083931A3 (en) New bestatin-related compounds as immunopotentiator
JPS56125306A (en) Transparent cosmetic
SU1114421A1 (ru) Состав дл лечени кариеса зубов
GB2165153B (en) Hydrosoluble pharmaceutical compositions containing salts of (-)cis-1,2-epoxypropylphosphonic acid with aminoacids
JPS57177656A (en) Honey containing chlorella
FI873496A7 (fi) Eläinten soluvasteiden modulointi isoksantopteriini-8-(1'-beta-aldogly kosidyyli)-johdannaisia sisältävilkoostumuksilla.
ES2001620A6 (es) Procedimiento para la obtencion de una solucion a base de luprostiol
JPS559046A (en) Composition for skin application
IT8222908A0 (it) Composizioni utili nella terapia dell'alcoolismo contenenti come principio attivo 3-aroil-butirrolattoni

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee